RESUMO: O objetivo deste estudo foi avaliar dois aditivos alimentares, um a base de butirato de sódio encapsulado (Adimix® Precision) (AD) e outro a base de um fitogênico (Apex® 5) (AX), associados ou não a um antibiótico promotor de crescimento (tilosina), durante as fases de crescimento e terminação, sobre o desempenho, características da carcaça e status de saúde. Foram utilizados 300 suínos machos castrados e fêmeas distribuídos em seis tratamentos em um delineamento em blocos casualizados com dez repetições. Os tratamentos consistiram em um controle negativo (CN), controle positivo (CP) (tilosina), AD (butirato de sódio encapsulado), AX (fitogênico), CP+AD (tilosina+butirato de sódio encapsulado) e CP+AX (tilosina+fitogênico). Os dados de desempenho (peso vivo, consumo diário de ração, ganho de peso médio diário e conversão alimentar) e de carcaça (peso de carcaça, espessura de toucinho, profundidade do lombo e carne magra na carcaça) foram submetidos à ANOVA seguido por teste de Tukey, e os dados de condição de saúde (ocorrência de doenças, animais eutanasiados e mortos espontaneamente) foram analisados pelo teste de χ2. Os animais do grupo AD apresentaram maior ganho de peso diário (GPD) durante o período de avaliação e maior peso vivo aos 120, 140 e 164 dias de idade, além de maior peso de carcaça em comparação aos grupos CN e CP. O tratamento AX aumentou o GPD na fase crescimento II e o peso vivo aos 120 e 140 dias de idade em relação ao CN. O grupo CP+AX apresentou maior peso final em relação aos grupos CN e CP e maior peso de carcaça em relação ao CN. Não houve diferença entre os tratamentos para espessura de toucinho, porcentagem de carne magra na carcaça e ocorrência de doenças e óbitos. A inclusão de butirato de sódio encapsulado (tratamento AD) foi efetiva no aumento de GPD, peso final e peso de carcaça em comparação à suplementação com tilosina (tratamento CP), assim como a inclusão fitogênico (tratamento AX) melhorou a conversão alimentar em comparação ao grupo CP.

ABSTRACT: The aim of this study was to evaluate two feed additives, one based on encapsulated sodium butyrate (Adimix® Precision) (AD) and the other, a phytogenic (Apex® 5) (AX), associated or not with an antimicrobial growth promoter (tylosin) during the growth and finishing phases on performance, carcass characteristics and health conditions. A total of 300 barrows and females were distributed in six treatments in a randomized block design with ten replicates. The treatments consisted of a negative control (NC), positive control (PC) (tylosin), AD (encapsulated sodium butyrate), AX (phytogenic), PC+AD (tylosin+encapsulated sodium butyrate), and PC+AX (tylosin+phytogenic). The performance (live weight, daily feed intake, average daily gain and feed conversion) and carcass data (carcass weight, backfat thickness, loin depth, lean meat on the carcass) were submitted to ANOVA plus Tukey’s test, and the health conditions (occurrence of diseases, culling, and spontaneous deaths) were analyzed by χ2. Animals of the AD group had the highest average daily gain (ADG) over the evaluation period and the highest live weight at 120, 140, and 164 days of age, in addition to the highest carcass weight compared to NC and PC groups. The AX treatment increased the ADG in growth phase II and the live weight at 120 and 140 days of age in relation to the NC. The PC+AX group had a higher final live weight compared to the NC and PC groups and higher carcass weight in relation to the NC group. There was no difference among treatments for backfat thickness, percentage of lean meat in the carcass, or occurrence of diseases and deaths. The inclusion of encapsulated sodium butyrate (AD treatment) was effective in increasing ADG, final live weight, and carcass weight compared to supplementation with tylosin (PC treatment), as was the inclusion of a phytogenic (AX treatment) on FC compared to the PC.

ABSTRACT The objective of this study was to describe the housing system in the hospital pens on growing and finishing (GF) pig farms. This work was developed by using a questionnaire and was conducted between January and April, 2016. Forty-four GF commercial farms (a total of 41,111 animals) were involved, seeking to raise issues concerning the facilities of the hospital pens, environment, management, feeding and the reasons for transferring the animals to these accommodations. About 98% of the evaluated farms had, at least, one hospital pen. Most of these farms presented a percentage of animals evaluated (PAE) in the infirmary, of less than 1.5% of the total capacity of the animal housing on the farm. In 93.48% of the farms, the criterion used to transfer the animals to the infirmaries was when they were identified as “impaired, hurt, suffering”. In 47.83% of the cases, there were no differences between the hospital and common pens regarding the general management of the animals. The facilities and environment characteristics were similar in almost all hospital pens. Respiratory problems were the main reason for transferring pigs from the common to hospital pens. Under the conditions of this study, sufficient hospital pens exist on farms and overcrowding or competition for resources among pigs are avoided. However, there is no established standard among respondents about where to place the recovered animals.

ABSTRACT The objective of this study was to identify and quantify, through mathematical models, the main factors of production in growing and finishing pig units linked to three Brazilian cooperatives located in Western Region of Paraná State that influence the parameters of daily feed intake and feed conversion ratio. The records of 216 growing and finishing farms from 2010 to 2013, representing 1,533 batches, and totaling approximately 1,025,000 pigs, were evaluated. Thirty production factors related to the management, health, installations and equipment, nutrition, genetics, and environment were considered. The number of pigs per pen, the feeder model, the origin and sex of the animals, and the initial and final body weights were the factors included in the final models for both dependent variables (daily feed intake and feed conversion ratio) and had a significant impact on these ratios. Approximately, 41 and 55% of the total variance found for daily feed intake and feed conversion ratio, respectively, were explained by the variables included in the final models. Mathematical models could serve as important tools to aid the decision-making in pig production systems.

ABSTRACT The objective of this study was to evaluate the effect of chelated iron supplementation on gestating and lactating sows and on their suckling and weaned piglets. Reproductive traits, piglet performance, hematological parameters, and the iron concentrations in colostrum, milk, and stillborn livers were measured. Ninety-six sows were subjected to one of three treatment groups. Group T1 comprised pregnant and lactating sows treated with diets supplemented with inorganic iron (551 mg Fe/kg) and suckling piglets administered 200 mg of injectable iron dextran. Group T2 was the same as T1, except that sows after 84 days of gestation, lactating sows, and suckling piglets were fed a diet supplemented with 150 mg Fe/kg of chelated iron, and suckling piglets were administered injectable iron dextran. Group T3 was the same as T2 but without injectable iron dextran for suckling piglets. During the nursery phase, all of the weaned piglets were penned with their original groups or treatments and received isonutritive and isocaloric feeds. Piglets from the T2 and T3 groups also received an additional 150 mg Fe/kg of chelated iron via their feed. There were no differences among the treatments for reproductive traits or the iron concentrations in the colostrum, milk, or liver. The piglets that did not receive the injectable iron dextran showed the poorest performance during the pre-and post-weaning phases and showed the poorest hematological parameters of the suckling piglets. The chelated iron supplementation is insufficient to meet piglet demand. The iron dextran supply is necessary for suckling and weaned piglets.

O bem-estar animal é um tema de crescente preocupação mundial. A partir da década de 1960, a Europa centralizou as discussões sobre a questão, provocou o nascimento desta ciência e promoveu o desenvolvimento de normas relacionadas. Atualmente, os padrões europeus de bem-estar na criação de suínos constituem-se referências mundiais, podendo representar futuramente potenciais barreiras mercadológicas para a comercialização da carne suína. O Brasil é um dos maiores produtores e exportadores desta proteína animal, e intensificou suas ações com objetivo de se adequar a este novo cenário. O objetivo deste documento é avaliar a viabilidade da suinocultura industrial brasileira em aplicar os padrões europeus de bem-estar em seu atual sistema produtivo. Os níveis de complexidade estruturais e de manejo e as vantagens potenciais do Brasil neste contexto são discutidas, e um cenário a priori positivo mostra que o país tem várias facilidades para a adequação da maioria das exigências praticadas

Animal welfare is an issue of growing concern worldwide. Since the 1960s, Europe has led the discussions on this subject, developing the supporting science and the necessary standards. Currently, European welfare standards on pig farms set the global standards and may represent a potential marketing barrier for commercial pork production. Brazil is one of the largest producers and exporters of pork and has intensified efforts to adapt to the new standards. The objective of this paper is to assess the feasibility of applying European welfare standards to Brazilian industrial pig farming. The complexity of the required changes and the potential advantages to Brazil are discussed, and it is concluded that Brazil has the resources to meet the majority of the requirements